Motivity’s Calmanac Acquisition Is About More Than Practice Management
Last year, when Five Elms Capital invested $27M into Motivity, I wrote that the underlying strategic question was not the investment itself, but whether Motivity intended to evolve beyond a clinical platform into broader operational infrastructure for autism care organizations.
This week's announcement provides a much clearer answer.
